sb 239063 has been researched along with Lung Neoplasms in 1 studies
SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bistrović, A | 1 |
| Krstulović, L | 1 |
| Harej, A | 1 |
| Grbčić, P | 1 |
| Sedić, M | 1 |
| Koštrun, S | 1 |
| Pavelić, SK | 1 |
| Bajić, M | 1 |
| Raić-Malić, S | 1 |
1 other study available for sb 239063 and Lung Neoplasms
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer.
Topics: Amidines; Antineoplastic Agents; Apoptosis; Benzimidazoles; Carcinoma, Non-Small-Cell Lung; Cell Pro | 2018 |